146.12 USD
↗ 2.68 (1.87%)AT CLOSE (11:59 AM EDT)
Gilead Sciences Inc
GILDNASDAQ • USD
146.11
↘ 0.02 (0.01%)
POST MARKET (AS OF 07:57 PM EDT)
Post Market
AS OF 07:57 PM EDT
146.11
↘ 0.02 (0.01%)
Market: CLOSED
Gilead Sciences Inc (GILD) trades at $146.12 per share. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics place GILD at a fair price relative to peers.
Technical & fundamental data as of Aug 21, 2026.
Open?$144.52
High?$147.91
Low?$143.50
Prev. Close?$143.44
Volume?5.4M
Avg. Volume?6.4M
VWAP?$146.24
Rel. Volume?0.84x
Bid / Ask
Bid?$146.00 × 300
Ask?$147.34 × 100
Spread?$1.34
Midpoint?$146.67
Valuation & Ratios
Market Cap?181.2B
Shares Out?1.2B
Float?1.2B
Float %?99.7%
P/E Ratio?N/A
P/B Ratio?15.32
EPS?-$2.61
Dividend?2.25%
Ex-Dividend?2026-09-15
News
Profile
Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
Themes
Employees
17.0K
Market Cap
181.2B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
1992-01-22
Address
333 LAKESIDE DR
FOSTER CITY, CA 94404
Phone: (650) 574-3000
FOSTER CITY, CA 94404
Phone: (650) 574-3000
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?83
Momentum?33
Short Sent.?78
Piotroski F-Score?3/9Weak
Altman Z-Score?3.47Safe
Confidence?66%Moderate
Short InterestModerate
Short % of Float?1.97%Low
Short Interest?24.4M
Days to Cover?3.9
Free Float1.2B
Avg Daily Volume6.3M
Settlement Date2026-07-31
Financial Health
Current Ratio?1.27Adequate
Quick Ratio?1.09Adequate
Cash Ratio?0.29Low
Debt/Equity?2.22High
ValuationFAIRLY VALUEDvs 9 peers + S&P 500
Score53/100
P/E?N/A▾
P/B?15.32HIGH▾
Peers22
S&P11
P/S?5.95FAIR▾
Peers60
S&P22
P/FCF?14.0CHEAP▾
Peers100
S&P77
EV/EBITDA?63.3HIGH▾
Peers13
S&P3
EV/Sales?6.71HIGH▾
Peers60
S&P22
Returns & Efficiency
ROE?-27.4%WEAK▾
Peers14
S&P6
ROA?-6.6%WEAK▾
Peers13
S&P3
Cash Flow & Enterprise
FCF?$12.9B
Enterprise Value?$204.2B
Fundamentals ratios updated end of day